Cargando…
Management of Brain Cancer and Neurodegenerative Disorders with Polymer-Based Nanoparticles as a Biocompatible Platform
The blood–brain barrier (BBB) serves as a protective barrier for the central nervous system (CNS) against drugs that enter the bloodstream. The BBB is a key clinical barrier in the treatment of CNS illnesses because it restricts drug entry into the brain. To bypass this barrier and release relevant...
Autores principales: | Bazi Alahri, Mehdi, Jibril Ibrahim, Alhawarin, Barani, Mahmood, Arkaban, Hassan, Shadman, Seyedeh Malahat, Salarpour, Soodeh, Zarrintaj, Payam, Jaberi, Javad, Turki Jalil, Abduladheem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864049/ https://www.ncbi.nlm.nih.gov/pubmed/36677899 http://dx.doi.org/10.3390/molecules28020841 |
Ejemplares similares
-
Recent Advances in Nanotechnology for the Management of Klebsiella pneumoniae–Related Infections
por: Barani, Mahmood, et al.
Publicado: (2022) -
Fabrication of Fe(III)-doped mesoporous silica nanoparticles as biocompatible and biodegradable theranostic system for Remdesivir delivery and MRI contrast agent
por: Arkaban, Hasan, et al.
Publicado: (2023) -
Polyacrylic Acid Nanoplatforms: Antimicrobial, Tissue Engineering, and Cancer Theranostic Applications
por: Arkaban, Hassan, et al.
Publicado: (2022) -
Gastrointestinal Involvement in Long COVID and Potential Pathogenic Mechanisms
por: Jadali, Zohreh, et al.
Publicado: (2022) -
Long COVID and ophthalmology: New insights into underlying disease mechanisms
por: Jadali, Zohreh, et al.
Publicado: (2022)